Scott V Bratman, MD PhD
Scott V Bratman, MD PhD
Senior Scientist (Principal Investigator), Princess Margaret Cancer Centre, University Health
Verified email at - Homepage
Cited by
Cited by
The prognostic landscape of genes and infiltrating immune cells across human cancers
AJ Gentles, AM Newman, CL Liu, SV Bratman, W Feng, D Kim, VS Nair, ...
Nature medicine 21 (8), 938-945, 2015
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
AM Newman, SV Bratman, J To, JF Wynne, NCW Eclov, LA Modlin, ...
Nature medicine 20 (5), 548-554, 2014
Integrated digital error suppression for improved detection of circulating tumor DNA
AM Newman, AF Lovejoy, DM Klass, DM Kurtz, JJ Chabon, F Scherer, ...
Nature biotechnology 34 (5), 547-555, 2016
Prediction of acute myeloid leukaemia risk in healthy individuals
S Abelson, G Collord, SWK Ng, O Weissbrod, N Mendelson Cohen, ...
Nature 559 (7714), 400-404, 2018
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
SY Shen, R Singhania, G Fehringer, A Chakravarthy, MHA Roehrl, ...
Nature 563 (7732), 579-583, 2018
Circulating tumor DNA and liquid biopsy in oncology
DW Cescon, SV Bratman, SM Chan, LL Siu
Nature Cancer 1 (3), 276-290, 2020
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
DM Kurtz, MR Green, SV Bratman, F Scherer, CL Liu, CA Kunder, ...
Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
SV Bratman, SYC Yang, MAJ Iafolla, Z Liu, AR Hansen, PL Bedard, ...
Nature Cancer 1 (9), 873-881, 2020
FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution
AM Newman, SV Bratman, H Stehr, LJ Lee, CL Liu, M Diehn, AA Alizadeh
Bioinformatics 30 (23), 3390-3393, 2014
Identification and Use of Circulating Nucleic Acid Tumor Markers
M Diehn, AA Alizadeh, AM Newman, SV Bratman
US Patent App. 14/774,518, 2016
Nasopharyngeal cancer: molecular landscape
JP Bruce, K Yip, SV Bratman, E Ito, FF Liu
Journal of Clinical Oncology 33 (29), 3346-3355, 2015
Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis
X Zhao, P Psarianos, LS Ghoraie, K Yip, D Goldstein, R Gilbert, I Witterick, ...
Nature metabolism 1 (1), 147-157, 2019
Bioactive DNA from extracellular vesicles and particles
EZ Malkin, SV Bratman
Cell Death & Disease 11 (7), 584, 2020
Stabilization of overlapping microtubules by fission yeast CLASP
SV Bratman, F Chang
Developmental cell 13 (6), 812-827, 2007
Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA
SY Shen, JM Burgener, SV Bratman, DD De Carvalho
Nature protocols 14 (10), 2749-2780, 2019
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates
O Kis, R Kaedbey, S Chow, A Danesh, M Dowar, T Li, Z Li, J Liu, ...
Nature communications 8 (1), 15086, 2017
Senescence, necrosis, and apoptosis govern circulating cell-free DNA release kinetics
A Rostami, M Lambie, WY Caberry, V Stambolic, JN Waldron, SV Bratman
Cell reports 31 (13), 2020
Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity‐modulated radiotherapy
F Caparrotti, SH Huang, L Lu, SV Bratman, J Ringash, A Bayley, J Cho, ...
Cancer 123 (19), 3691-3700, 2017
Long-term late toxicity, quality of life, and emotional distress in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy
LJ McDowell, K Rock, W Xu, B Chan, J Waldron, L Lu, S Ezzat, D Pothier, ...
International Journal of Radiation Oncology* Biology* Physics 102 (2), 340-352, 2018
Identification and use of circulating tumor markers
M Diehn, AA Alizadeh, AM Newman, SV Bratman
US Patent App. 14/209,807, 2014
The system can't perform the operation now. Try again later.
Articles 1–20